Company News 28 Oct 2021 Orthocell featured as a Case Study in the Australian Regenerative Medicine Therapies Report Orthocell’s CelGroâ„¢ technology has been featured as one of only four case studies in the recent Australian Regenerative Medicine Therapies… Orthocell
Company News 28 Oct 2021 Investor Presentation | Canaccord Genuity South-West Connect ASX Showcase Orthocell MD, Paul Anderson, presented at the Canaccord Genuity South-West Connect ASX Showcase today to share the latest news and… Orthocell
Media 15 Sep 2021 Orthocell (ASX:OCC) announces positive data on CelGro collagen rope for ACL repair Orthocell has been featured in The Market Herald, following our announcement of positive data from a pre-clinical study for anterior… Orthocell
Media 07 Sep 2021 Orthocell (ASX:OCC) granted patents in Canada and Hong Kong for CelGro Orthocell has been featured in The Market Herald, following our announcement of patents granted in Canada and Hong Kong for… Orthocell
Media, Video 02 Sep 2021 Video | Proactive Investors – September 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media 31 Aug 2021 Orthocell’s (ASX:OCC) final patient completes treatment in tendon regeneration study Orthocell has been featured in The Market Herald, highlighting the follow-up announcement from our OrthoATI™ rotator cuff tendon regeneration study. Orthocell
Media, Video 03 Aug 2021 Video | Proactive Investors – Orthocell highlights potential for CelGro in treatment of lymphedema Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGroâ„¢ with… Orthocell
Media 02 Aug 2021 Orthocell (ASX:OCC) has breakthrough tissue engineering study published in US Orthocell has been featured in The Market Herald, following the publication of our breakthrough tissue engineering study in the peer-reviewed… Orthocell
Media 13 Jul 2021 Orthocell (ASX:OCC) appoints exclusive distributor for Striate+ Orthocell has been featured in The Market Herald, announcing the appointment of Samson Medical Technologies (SMT) as its exclusive distributor for… Orthocell
Media, Video 27 Jun 2021 Video | Stockhead Investor Presentation – June 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Oriel Morrison as part of Stockhead V-Con Biotechs. Orthocell
